Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Angermeyer

Showing results (101-110 of 202) with videos related to

Pageof 21
Sort By:
Acta Psychiatrica Scandinavica. Supplementum|May 7, 2004
The European Study of the Epidemiology of Mental Disorders (ESEMeD) project: an epidemiological basis for informing mental health policies in EuropeJ Alonso, M C Angermeyer, J P Lépine, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|March 25, 2005
[Health Status of the German population: results of a representative survey using the EuroQol questionnaire]H H König, S Bernert, M C Angermeyer
Zeitschrift Fur Gerontologie|January 1, 1986
[Sex-dependent variations in the institutional career of mentally ill older patients]A Majcher-Angermeyer, M C Angermeyer, U Döcke
Psychiatrische Praxis|December 5, 2000
[Depression and stigma]K Stengler-Wenzke, M C Angermeyer, H Matschinger
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|January 3, 2007
[Strategies against the stigmatisation of mentally ill subjects and their practical realisation in the example of Irrsinnig Menschlich e. V]I Winkler, M Richter-Werling, M C Angermeyer
Psychiatrische Praxis|June 16, 2001
[Etiology of schizophrenia from the viewpoint of family]A Holzinger, P Müller, S Priebe, et al.
The International Journal of Social Psychiatry|July 4, 2001
Quality of life--as defined by schizophrenic patients and psychiatristsM C Angermeyer, A Holzinger, R Kilian, et al.
Pharmacopsychiatry|June 14, 2003
Schizophrenic patients' subjective reasons for compliance and noncompliance with neuroleptic treatmentW Löffler, R Kilian, M Toumi, et al.
Journal of Neurology|January 1, 1988
Geographical distribution of mortality rates for cerebrovascular disease in Lower Saxony (Federal Republic of Germany)M C Angermeyer, K Buser, U Patzold, et al.
Acta Psychiatrica Scandinavica|July 6, 2004
Quality of life in persons with schizophrenia in out-patient treatment with first- or second-generation antipsychoticsR Kilian, S Dietrich, M Toumi, et al.
Pageof 21

Showing results (101-110 of 202) with videos related to

Sort By:
Pageof 21
Acta Psychiatrica Scandinavica. Supplementum|May 7, 2004
The European Study of the Epidemiology of Mental Disorders (ESEMeD) project: an epidemiological basis for informing mental health policies in EuropeJ Alonso, M C Angermeyer, J P Lépine, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|March 25, 2005
[Health Status of the German population: results of a representative survey using the EuroQol questionnaire]H H König, S Bernert, M C Angermeyer
Zeitschrift Fur Gerontologie|January 1, 1986
[Sex-dependent variations in the institutional career of mentally ill older patients]A Majcher-Angermeyer, M C Angermeyer, U Döcke
Psychiatrische Praxis|December 5, 2000
[Depression and stigma]K Stengler-Wenzke, M C Angermeyer, H Matschinger
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|January 3, 2007
[Strategies against the stigmatisation of mentally ill subjects and their practical realisation in the example of Irrsinnig Menschlich e. V]I Winkler, M Richter-Werling, M C Angermeyer
Psychiatrische Praxis|June 16, 2001
[Etiology of schizophrenia from the viewpoint of family]A Holzinger, P Müller, S Priebe, et al.
The International Journal of Social Psychiatry|July 4, 2001
Quality of life--as defined by schizophrenic patients and psychiatristsM C Angermeyer, A Holzinger, R Kilian, et al.
Pharmacopsychiatry|June 14, 2003
Schizophrenic patients' subjective reasons for compliance and noncompliance with neuroleptic treatmentW Löffler, R Kilian, M Toumi, et al.
Journal of Neurology|January 1, 1988
Geographical distribution of mortality rates for cerebrovascular disease in Lower Saxony (Federal Republic of Germany)M C Angermeyer, K Buser, U Patzold, et al.
Acta Psychiatrica Scandinavica|July 6, 2004
Quality of life in persons with schizophrenia in out-patient treatment with first- or second-generation antipsychoticsR Kilian, S Dietrich, M Toumi, et al.
Pageof 21